一种简单的环氧化物修饰策略,用于构建氨基功能多2-醇) mRNA传递载体
Kuncheng Lv1,2, Yibo Qi1,2, Hanqin Zhao1,2
1State Key Laboratory of Polymer Science and Technology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences Changchun 130022 China wtsong@ciac.ac.cn.
Chemical science
|October 8, 2025
概括
新的多二氧化 (POx) 聚合物有效地为疫苗和基因疗法提供信使RNA (mRNA). 工程PAmOx聚合物显著提高mRNA转染,并显示出有希望的体内表达和瘤抑制能力.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 基因治疗 基因治疗
- 疫苗学 疫苗学 疫苗学
背景情况:
- 使者RNA (mRNA) 传递载体对于疫苗和基因疗法至关重要.
- 基于聚合物的载体提供可调节的结构和生物相容性,但面临效率挑战.
- 聚二氧化) (POx) 是一个有前途的生物材料,在mRNA传递方面探索有限.
研究的目的:
- 为了设计基于多[2-(5-氨基) -2-氧沙]的聚合物 (PAmOx) 作为高效的mRNA传递载体.
- 研究聚合度和移植的环氧化物分子对mRNA递送效率的影响.
- 评估基于PAmOx的新型mRNA载体的体外和体内性能.
主要方法:
- PAmOx和环氧化物分子 (1,2-epoxydecane) 之间的一步环开反应产生DP50-PE6.6.
- 在体外评估mRNA转染效率.
- 在体内研究涉及肌内和静脉注射在小鼠模型.
- 使用DP50-PE6/mOVA复合物与抗PD1疗法进行瘤生长抑制试验.
主要成果:
- 与母PAmOx相比,DP50-PE6的mRNA转染效率增加了3.3 × 10 ^ 5倍.
- 在体内肌肉内给药显示,mRNA在注射部位表达强,持续两天.
- 静脉注射导致选择性脏向 (85.1%的总表达).
- 与抗PD1结合DP50-PE6/mOVA在黑色素瘤模型中实现了90%以上的瘤抑制.
结论:
- 工程PAmOx聚合物,特别是DP50-PE6,是高效的mRNA传递载体.
- 这些基于POx的载体表现出有希望的体内生物分布和治疗潜力.
- 该研究强调了基于POx的材料在推进核酸输送技术方面的巨大潜力.
相关概念视频
Preparation of Epoxides
9.1K
Overview
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy acids to...
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy acids to...
9.1K
RNA Editing
9.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.8K


